Dr Aaminah Khan
0001-01-01
Early-Career
Dr Aaminah Khan is an early-career researcher at the Children's Cancer Institute in the brain tumour group and a conjoint associate lecturer at the University of New South Wales. She earned her doctorate in January 2021, becoming the first to receive a research PhD in Australia with a focus on diffuse intrinsic pontine glioma (DIPG). Her research revolves around developing novel therapeutic strategies for paediatric brain tumours, leveraging metabolic and epigenetic inhibitors. With a strong background in drug testing using patient-derived brain cancer cell lines and orthotopic animal models, she is devoted to translational research, bridging the gap between the lab and clinical trials.
Dr Aaminah Khan is an early-career researcher at the Children's Cancer Institute in the brain tumour group and a conjoint associate lecturer at the University of New South Wales. She earned her doctorate in January 2021, becoming the first to receive a research PhD in Australia with a focus on diffuse intrinsic pontine glioma (DIPG). Her research revolves around developing novel therapeutic strategies for paediatric brain tumours, leveraging metabolic and epigenetic inhibitors. With a strong background in drug testing using patient-derived brain cancer cell lines and orthotopic animal models, she is devoted to translational research, bridging the gap between the lab and clinical trials.
